COVID-19 TESTING: ROCHE DIAGNOSTICS ROBUST PORTFOLIO

Session

Medicine and Nursing

Description

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a new social order worldwide. The COVID-19 pandemic outbreak has affected many countries causing hundred thousand of deaths all around the world. It did not exercise its influence only on the citizens' health status, but also had a tremendous impact on the economy and financial status of many countries. Nevertheless, all its clinical manifestations are still being elucidated. Together with its spread, proper protective measures, early and accurate detection of the COVID-19 became the most crucial and challenging step. Therefore, facing this global situation and need, Roche Diagnostics responded by launching the most innovative and accurate diagnostic assays towards fast, robust, and accurate detection of SARS-CoV-2. Here we present eight distinct diagnostic approaches covering molecular and serological testing for the evaluation of patient's health condition, infectiousness and their exposure to the virus. All these tests have demonstrated high accuracy and precision with over 99.5% sensitivity and specificity as they were validated throughout a large number of samples.

Keywords:

SARS-CoV-2, COVID-19, molecular testing, serological testing, Roche Diagnostics.

Session Chair

Ferat Sallahu

Session Co-Chair

Haki Jashari

Proceedings Editor

Edmond Hajrizi

ISBN

978-9951-437-96-7

Location

Lipjan, Kosovo

Start Date

31-10-2020 10:45 AM

End Date

31-10-2020 12:15 PM

DOI

10.33107/ubt-ic.2020.424

This document is currently not available here.

Share

COinS
 
Oct 31st, 10:45 AM Oct 31st, 12:15 PM

COVID-19 TESTING: ROCHE DIAGNOSTICS ROBUST PORTFOLIO

Lipjan, Kosovo

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a new social order worldwide. The COVID-19 pandemic outbreak has affected many countries causing hundred thousand of deaths all around the world. It did not exercise its influence only on the citizens' health status, but also had a tremendous impact on the economy and financial status of many countries. Nevertheless, all its clinical manifestations are still being elucidated. Together with its spread, proper protective measures, early and accurate detection of the COVID-19 became the most crucial and challenging step. Therefore, facing this global situation and need, Roche Diagnostics responded by launching the most innovative and accurate diagnostic assays towards fast, robust, and accurate detection of SARS-CoV-2. Here we present eight distinct diagnostic approaches covering molecular and serological testing for the evaluation of patient's health condition, infectiousness and their exposure to the virus. All these tests have demonstrated high accuracy and precision with over 99.5% sensitivity and specificity as they were validated throughout a large number of samples.